The syntheses and in vitro
antimalarial screening of 50 bridged, bicyclic endoperoxides of types 9-13 are reported. In contrast to
antimalarial trioxanes of the
artemisinin family, but like
yingzhaosu A and
arteflene, the
peroxide function of compounds 9-13 is contained in a 2,3-dioxabicyclo[3.3.1]
nonane system 6.
Peroxides 9 and 10 (R(1) =
OH) are readily available through a multicomponent, sequential,
free-radical reaction involving
thiol-
monoterpenes co-oxygenation (a TOCO reaction). beta-Sulfenyl
peroxides 9 and 10 (R(1) =
OH) are converted into beta-sulfinyl and beta-sulfonyl
peroxides of types 11-13 by controlled S-oxidation and manipulation of the tert-
hydroxyl group through acylation, alkylation, or
dehydration followed by selective hydrogenation. Ten enantiopure beta-sulfonyl
peroxides of types 12 and 13 exhibit in vitro
antimalarial activity comparable to that of
artemisinin (IC(50) = 6-24 nM against Plasmodium falciparum NF54). In vivo testing of a few selected
peroxides against Plasmodium berghei N indicates that the
antimalarial efficacies of beta-sulfonyl
peroxides 39a, 46a, 46b, and 50a are comparable to those of some of the best
antimalarial drugs and are higher than
artemisinin against
chloroquine-resistant Plasmodium yoelii ssp. NS. In view of the nontoxicity of beta-sulfonyl
peroxides 39a, 46a, and 46b in mice, at high dosing, these compounds are regarded as promising
antimalarial drug candidates.